Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · Real-Time Price · USD
0.915
+0.035 (3.99%)
Dec 20, 2024, 4:00 PM EST - Market closed
Cytosorbents Employees
Cytosorbents had 186 employees as of December 31, 2023. The number of employees decreased by 12 or -6.06% compared to the previous year.
Employees
186
Change (1Y)
-12
Growth (1Y)
-6.06%
Revenue / Employee
$202,901
Profits / Employee
-$100,376
Market Cap
50.03M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
SHL Telemedicine | 583 |
Singular Genomics Systems | 255 |
Celularity | 120 |
iCAD, Inc. | 69 |
IO Biotech | 68 |
Spero Therapeutics | 46 |
Iterum Therapeutics | 14 |
MAIA Biotechnology | 13 |
CTSO News
- 9 days ago - CytoSorbents to Host Investor Meetings in San Francisco During J.P. Morgan Healthcare Conference Week - GlobeNewsWire
- 5 weeks ago - CytoSorbents And Converge Biotech Announce Strategic Partnership to Expand Sepsis and Critical Care Treatment with CytoSorb in India - GlobeNewsWire
- 6 weeks ago - Cytosorbents Corporation (CTSO) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - CytoSorbents Submits DrugSorb-ATR Marketing Application to U.S. FDA to Reduce the Severity of Bleeding in Heart Bypass Surgery Patients on the Blood Thinner Ticagrelor and Provides Business Update - GlobeNewsWire
- 4 months ago - CytoSorbents to Present at the H.C. Wainwright 26ᵗʰ Annual Global Investment Conference - GlobeNewsWire
- 4 months ago - CytoSorbents Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 months ago - Cytosorbents Corporation (CTSO) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - CytoSorbents Reports Second Quarter 2024 Financial and Operational Results - GlobeNewsWire